P B Gaudin

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases
    P B Gaudin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 22:148-62. 1998
  2. ncbi Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues
    P B Gaudin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 23:1021-31. 1999
  3. ncbi Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
    C Cordon-Cardo
    Memorial Sloan Kettering Cancer, New York, NY 10021, USA
    J Natl Cancer Inst 90:1284-91. 1998
  4. ncbi Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma
    E M Genega
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Mod Pathol 13:1186-91. 2000
  5. ncbi Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
    S S Chang
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Urology 57:801-5. 2001
  6. ncbi Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma
    S S Chang
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Urology 57:1179-83. 2001

Collaborators

Detail Information

Publications6

  1. ncbi Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases
    P B Gaudin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 22:148-62. 1998
    ..Based on their distinctive histologic appearance and immunohistochemical profile, PSPUMP and PSS can be differentiated from other mesenchymal lesions of the prostate...
  2. ncbi Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissues
    P B Gaudin
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Am J Surg Pathol 23:1021-31. 1999
    ..The effects of 3DCRT on prostate cancer are variable, with some cases showing profound therapy-related changes and others showing no apparent therapy effect...
  3. ncbi Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
    C Cordon-Cardo
    Memorial Sloan Kettering Cancer, New York, NY 10021, USA
    J Natl Cancer Inst 90:1284-91. 1998
    ..This study was undertaken to identify and to assess potential alterations of p27KIP1 gene expression in patients with benign prostatic hyperplasia (BPH) and patients with prostate cancer...
  4. ncbi Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma
    E M Genega
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Mod Pathol 13:1186-91. 2000
    ..The first three antibodies should be used initially; if results are negative, the remaining antibodies may be employed...
  5. ncbi Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen
    S S Chang
    Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
    Urology 57:801-5. 2001
    ..The neovascular endothelial cells of metastatic clear cell renal carcinoma, however, express PSMA. This expression may make PSMA an effective target for mAb-based antineovasculature therapy in metastatic renal carcinoma...
  6. ncbi Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma
    S S Chang
    Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA
    Urology 57:1179-83. 2001
    ..The mAb 7E11 is currently used in the radioisotopic evaluation of prostate cancer, and its immunohistochemical properties have been examined in primary prostate cancer specimens...